ALK-positive NSCLC
Roche’s Alecensa beats chemo in early-stage lung cancer, following Tecentriq’s lead
Anika Sharma
With Tecentriq approval, Roche is once again celebrating success, this time in a promising early-stage lung cancer trial starring Alecensa, ...
